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The effect of a 36-session Cardiac Rehabilitation
Program on the Framingham Risk Score
By
Veronica K. Gonzales
B.S., Exercise Science, University of New Mexico, 2007
ABSTRACT

Cardiac Rehabilitation is widely used in the United States to help individuals who
have had a cardiac event that is approved by insurance companies. Factors that lead to the
development of cardiovascular disease are lack of exercise, tobacco use, obesity, high
blood pressure, high cholesterol levels, and diet comprised of high consumption of
saturated fats, salt, refined carbohydrates, and low levels of fruits and vegetables (World
Health Organization, 2008). The purpose of this study is to examine the effectiveness of a
cardiac rehabilitation program in modifying the patient’s Framingham risk score after 36
sessions of cardiac rehabilitation. This is a retrospective study; data were taken from
subject files that were acquired during the period of April 2005 to March 2008. The study
included 152 male and 46 female subjects.
Baseline and 12-week values for blood pressure (systolic, diastolic), total
cholesterol, HDL-C, and LDL-C, smoking status and diabetes status was collected. To
evaluate each of the subject’s data and form a Framingham risk score for each subject a
computer program was developed using the Labview (National Instruments, Austin
Texas). Statistical significance was found in all variables (Framingham risk score p<.001,
systolic blood pressure p=.049, diastolic blood pressure p= .002, total cholesterol p<.001,
LDL-C p<.001, HDL-C p.004) between baseline and post cardiac rehabilitation program.
v
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There was mild statistical significance between delta fat and the delta Framingham scores
p= .004. There was no statistical significance found in between delta Framingham and
delta MET p= .817.
Cardiac rehabilitation programs are an important part in improving an individual’s
health after a coronary event. Cardiac rehabilitation programs include education to
improve an individual’s diet skills for handling stress and improve their outlook on life
after their recent cardiac event as well as reducing their risk for another coronary event.
The Framingham risk score is an assessment tool that is widely accepted to evaluate risk
factors that lead to the development of coronary heart disease. However there was
research that showed that it underestimated an individual’s risk for developing coronary
heart disease.
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Chapter I
Introduction

Cardiovascular disease affected 80,000,000 individuals in the United States in
2006 (American Heart Association, 2008). Cardiovascular disease is an umbrella term
that includes coronary heart disease, rheumatic heart disease, cerebrovascular disease and
renal failure (American Heart Association, 2008). Factors that lead to the development of
cardiovascular disease are lack of exercise, tobacco use, obesity, high blood pressure,
high cholesterol levels, and diet comprised of high consumption of saturated fats, salt,
refined carbohydrates, and low levels of fruits and vegetables (World Health
Organization, 2008). Coronary heart disease is the leading cause of death in both men and
women in the United States. Coronary heart disease is a form of cardiovascular disease,
which includes all illnesses and diseases that affect the vessels going to and from the
heart. In cardiovascular disease the vessels become occluded with plaque, making it
difficult or impossible for blood to pass through. This occlusion may cause a myocardial
infarction, which is damage or death to the areas of the heart not getting enough blood
flow.
To qualify for a cardiac rehabilitation program an individual will have had a
myocardial infarction, stent, coronary artery bypass graft, valve replacement or repair,
heart transplant or new-onset angina. The American Heart Association (AHA), American
College of Sports Medicine (ACSM), and American Association of Cardiovascular and
Pulmonary Rehabilitation (AACVPR) have shown that cardiac rehabilitation programs
are beneficial in reducing the reoccurrence of another coronary event or death. However,
the exact reasons the programs are beneficial are unclear. In the past, cardiac
1

rehabilitation programs focused primarily on cardiovascular exercise to reduce the
incidence of another coronary event. Cardiac rehabilitation programs have expanded on
that theme and now include education and dietary recommendations to provide patients
with a multifaceted program. During the cardiac rehabilitation program data are collected
from blood tests, exercise tests, and questionnaires.
Cardiac rehabilitation programs are primarily housed in health care institutions
such as hospitals. AACVPR has developed guidelines and an accreditation for cardiac
rehabilitation programs, providing patients with information and lifestyle changes that
will prevent the reoccurrence of a cardiac event. Cardiac rehabilitation programs maintain
data per AACVPR policy to assess the efficacy of the program’s effectiveness in
reducing the risk of another coronary event. AACVPR has identified the major domains
that a cardiac rehabilitation program should have in order to acquire and maintain a
certification. The domains of AACVPR are behavioral (education, tobacco cessation,
stress management, adherence to diet, and exercise), clinical (functional capacity, lipids,
MET levels, weight, blood pressure, and heart rate), health (quality of life and loss of
work days), and service (patient satisfaction, access and utilization of service, and
financial and economic concerns). Even though cardiac rehabilitation programs have
been shown to reduce coronary events, more data is needed over a longer period of time
to understand and explain their effectiveness.
Framingham Risk Score & Framingham Heart Study
The Framingham risk score is a well-accepted tool in identifying the risk for the
development of coronary heart disease. The Framingham risk score is used to evaluate an
individual’s risk before a coronary event, and assess risk after the cardiac rehabilitation
2

intervention. Aspects of the Framingham risk score are age, gender, blood pressure, total
cholesterol, LDL-C, HDL-C, smoking, and diabetes. These factors are important in
assessing an individual’s risk for coronary heart disease as they give a physician an idea
of what is occurring in the body. Abnormal or high cholesterol values increase the risk
for developing atherosclerosis in the vessels of the heart. High blood pressure values
increase stress on the heart and can be caused by atherosclerosis. Smoking has been
shown to cause irritation in the vessels increasing the presence of plaque that leads to
atherosclerosis.
The Framingham Heart Study was a longitudinal study that gave great insight into
a variety of risk factors that lead to the development of coronary heart disease. The risk
factors that have been identified by the researchers in the Framingham heart study are
blood pressure (systolic and diastolic), cholesterol (HDL-C, LDL-C, and total
cholesterol); in addition, age and gender are important in identifying cardiovascular
disease risk over a 10-year period. The Framingham risk score evaluates each of the
values with equal importance and each sub-value is assigned a score based on the
distance away from “healthy” values. Since cardiac rehabilitation programs aim at
reducing the incidence of coronary heart disease, the Framingham risk score is
considered to be a reliable tool in evaluating cardiac rehabilitation programs.
Statement of the Problem
Cardiac rehabilitation programs are intended to help an individual after a cardiac
event (i.e., myocardial infarction, heart transplant, valve replacement or repair, coronary
artery bypass graft, percutaneous transluminal coronary angioplasty or percutaneous
transluminal coronary intervention). Much of the research done validating cardiac
3

rehabilitation programs focuses on the graduation rate and occurrence of another cardiac
event. The Framingham risk score appears to be a good instrument, but there may be
another instrument or a tool may need to be developed to better evaluate cardiac
rehabilitation programs.

Purpose
The purpose of this study is to examine the effectiveness of a cardiac
rehabilitation program to modify the patient’s Framingham risk score after 36 sessions of
cardiac rehabilitation. This research looked at data that has been acquired from a cardiac
rehabilitation program and evaluated the program by using the Framingham risk score.
This study contributed by identifying whether the current time frame of 12 weeks or 36
cardiac rehabilitation sessions of exercise is adequate.

Primary Research Questions
1. Is there a difference between the baseline and post data for the Framingham risk
score, blood pressure (systolic and diastolic), cholesterol (HDL, LDL, and total
cholesterol)?

Rationale
In current research exercise, proper nutrition, and smoking cessation have been shown to
reduce an individual’s risk for developing cardiovascular disease. AACVPR guidelines
require cardiac rehabilitation programs to include exercise, nutrition and smoking
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cessation. The Framingham risk score is a valid tool developed by National Institutes of
Health to identify those who are at risk for developing cardiovascular disease.
2. Do the changes in the Framingham risk score’s differ by age or gender?
Rationale
Research has shown that gender plays a role in the development of coronary heart disease
(Silander, K. et al., 2008). Females have protective hormones, such as estrogen, that
assist in the prevention of coronary heart disease.
Secondary Research Questions
3. Are there gender differences in the mean scores of the variables that make up the
Framingham risk score?
Rationale
Research has shown that gender plays a role in the development of coronary heart disease
(Silander, K. et al., 2008).
4. Are there age differences in the mean scores of the variables that make up the
Framingham risk score?
Rationale
The relationship of age to the mean scores or the variable may shed some light on
whether there is a difference in age and the variables.
5. Does gender interact with age for the Framingham risk score?
Rationale
The interaction of age and gender are important in identifying whether the belief that
females have a reduced risk for the development of coronary heart disease at younger
ages is true.
5

Assumptions
The following assumptions were made in this study:
1. The subjects were compliant with the cardiac rehabilitation program
2. The data collection was accurate.
Limitations
1. The Framingham risk score is intended to identify individuals who are at risk for
developing cardiovascular disease, not those who are diagnosed with
cardiovascular disease.
2. The Framingham risk score gives two different percentages for each individual;
one percentage uses the total cholesterol values and the other uses the LDL-C
value. Current research has shown that LDL values may show a better picture of
an individual’s future cardiac risk.
3. There are unequal numbers of men and women participants in the data acquired
for this study.
4. There was a variety of staff that assisted the subjects from the original walk test
through the 36 exercise sessions to the final walk test. As well as over the course
of three years the staff had changed.
5. The lab values that were used came from different laboratories.
6. There was a lack of control for the principal investigator and the progression of
exercise through out the program.
7. Subjects could attend cardiac rehabilitation anytime between 8am to 12pm and
1pm to 5pm, Monday, Wednesday and Friday. There was no time limit to
complete their exercise except for lunch and closing.
6

List of Terms
Atherosclerosis: A process of progressive thickening and hardening of the walls of
medium-sized and large arteries as a result of fat deposits on their inner lining.
Cardiovascular disease: the class of diseases that involve the heart or blood vessels
Carotid artery stenosis: a narrowing of the carotid arteries due to atherosclerosis, also
know as carotid artery disease
Catecholamines: hormones that are released during times of physical and emotional stress
(dopamine, norepinephrine, and epinephrine)
Coronary heart disease: is a narrowing of the small blood vessels that supply blood and
oxygen to the heart
Coronary artery disease: the disease state of the arteries of the heart due to the
accumulation of plaque
Coronary artery bypass graft: a surgical procedure performed to relieve angina and
reduce the risk of death; arteries or veins from elsewhere in the patient's body are grafted
to the coronary arteries to improve the blood supply to the coronary circulation
Cholesterol: a lipid, waxy steroid found in the cell membranes and transported in the
blood plasma of all animals
Cardiac rehabilitation program: is a multi-disciplinary program for individuals who have
cardiac disease to reduce reoccurrence of a cardiac event
Framingham Heart Study: a 1948 cardiovascular study to identify factors that increase an
individual’s risk for developing cardiovascular disease
Framingham risk score: an assessment tool that comprises of factors that the Framingham
heart study found to be predictors for developing cardiovascular disease
7

Myocardial infarction: i.e. heart attack that occurs when the blood supply to the heart is
disrupted
Occlusion: a blockage in the arteries or veins of the heart Stent: a man-made device used
to reopen vessels of the heart
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List of Abbreviations
AACVPR: American Association of Cardiac and Pulmonary Rehabilitation
ACC: American College of Cardiology
ACSM: American College of Sports Medicine
AHA: American Heart Association
CABG: coronary artery bypass graft
CDC: Centers for Disease Control
CHD: coronary heart disease
CVD: cardiovascular disease
HDL-C: high-density lipoproteins/ cholesterol
LDL-C: low-density lipoproteins/ cholesterol
MI: myocardial infarction
NO: nitric oxide
PTCA: percutaneous transluminal coronary angioplasty
PTCI: percutaneous transluminal coronary intervention
WHO: World Health Organization
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Chapter II
Literature Review
Coronary heart disease is the leading killer in both men and women in the United
States (CDC, 2007). In coronary heart disease (CHD) there is a buildup of atherosclerotic
plaque in the vessels and arteries in the cardiovascular system. Coronary heart disease is
a progressive disease that is caused by a combination of high blood pressure, a diet rich
in fat that causes plaque to build up in the veins and arteries of the heart and periphery,
and insufficient quality physical activity (exercise) (American Heart Association (AHA),
2008). The diagnosed forms of coronary heart disease are high blood pressure,
myocardial infarction and angina, stroke and heart failure (AHA, 2008). Coronary heart
disease is preventable through necessary lifestyle changes including diet, exercise,
smoking cessation, and diabetes management (Framingham Heart Study, 2008).
Etiology of CHD
The mechanism behind coronary heart disease is called atherosclerosis, the
buildup of plaque in the walls of the coronary arteries that are formed from fat,
cholesterol, calcium and other substances found in the blood (AHA, 2008). A secondary
response to the atherogenic factors leads to the development of a chronic inflammatory
response in the walls of the arteries. There is an accumulation of macrophages in the wall
of the arteries, caused by the build-up of low-density lipoproteins in the circulatory
system. The hardening of the artery is due to atherosclerosis that causes an increased
shear stress on the arteries. This shear stress on the smooth muscle cells of the arteries
activates the release of nitric oxide (NO) from the endothelial cells causing vasodilation.
However, the response to vasodilatation is restricted due to the atherosclerotic plaques
10

that have formed. In atherosclerosis there is an inability for the arteries to properly relax
due to the formation of plaque, which can cause high blood pressure. Atherosclerosis can
lead to the development of angina pectoris.
Angina pectoris is caused when the metabolic demand of the tissue exceeds the
ability of the compromised blood supply to meet those needs (Boron et al., 2009). There
are many things that can mimic angina pectoris within the body, such as acid reflux. One
way to diagnose angina is through an exercise stress test. There are a few patients who
experience no angina pectoris but can still have a silent ischemia. Common presentations
of angina include chest pain and discomfort, pressure, squeezing in the chest or feelings
of a heavy weight placed on the chest. Pressure can extend down the arm (left), neck,
jaw, shoulder or back (Mayo Clinic, 2009). There are different forms of angina: stable,
unstable and variant. Stable angina is exhibited when the heart works harder, for example
exertion, (duration is 5 minutes or less) and pain disappears at rest or with the use of
angina medication (Mayo Clinic, 2009). Unstable angina occurs even at rest, is
unexpected, lasts longer than stable angina and may not disappear with rest or use of
angina medication (Mayo Clinic, 2009). Variant angina usually happens when the heart is
resting, often is severe and may be relieved by angina medication (Mayo Clinic, 2009).
Angina in women can be different from common presentations. For instance, chest pain
may feel more stabbing, pulsating or sharp pain in the chest; nausea and abdominal pain
may be present (Mayo Clinic, 2009).
Treatment for individuals with stable angina is medication. Nitrates cause the
endothelial tissue of the veins and arteries to vasodilate through the release of nitric oxide
(Boron et al., 2009). Beta-blockers prevent the sympathetic nervous system from
11

stimulating β1 receptors in the myocardium, which in return reduce heart rate,
contractility and the metabolic demand (Boron et al., 2009). Calcium channel blockers
reduce contractility in the heart muscles and vascular smooth muscle (Boron et al., 2009).
If medication does not control angina and if the frequency and the severity increases,
medical interventions are needed such as a percutaneous transluminal coronary
intervention (PTCI) or percutaneous transluminal coronary angioplasty (PTCA). If the
vessel is fully occluded and a PTCI or PTCA cannot be placed in a coronary artery, then
a coronary artery bypass graft (CABG) may need to be performed. Even after medical or
surgical interventions, it is recommended that all individuals carry nitroglycerin with
them to prevent further complications related to the build-up of plaque.
Development of the Framingham Risk Score
The original Framingham risk score study was developed after World War II to
identify the causes behind individuals developing cardiovascular disease (Framingham
Heart Study, 2008). Cardiovascular disease was the foremost illness of the time since
infectious disease had been brought under control (Framingham Heart Study, 2008). By
1950, one out of every three men in the United States developed CVD before reaching
the age-sixty (Framingham Heart Study, 2008).
The subjects were recruited from Framingham, Massachusetts from a cohort of
the inhabitants. The original cohort was 5,209 men and women between the ages of 30
and 62; all subjects completed questionnaires and extensive physical exams every two
years since 1948. In 1971, the Framingham Study recruited 5,124 second-generation
children and spouses, of the original cohort. Due to the careful monitoring of the
Framingham subjects, important information was uncovered about cardiovascular disease
12

and the risk factors for developing cardiovascular disease. Risk factors for cardiovascular
disease include high blood pressure, high blood cholesterol, smoking, obesity, diabetes
and physical inactivity.
The data from the research showed a great deal of valuable information on the
effects of related factors such as blood triglyceride and HDL cholesterol levels, age,
gender, and psychosocial issues. Although the Framingham cohort was primarily
Caucasian, the importance of the major cardiovascular disease (CVD) risk factors
identified in this group have been shown in other studies to apply almost universally
among racial and ethnic groups, even though the patterns of distribution may vary from
group to group (Framingham Heart Study, 2008).
Aims of the Framingham Study are as follows (Dawber and Moore, 1952):
* First, to secure epidemiological data on atherosclerotic and hypertensive CVD.
* Second, to secure data on the prevalence of all forms of CVD in a representative
population sample.
* Third, to test the efficiency of various diagnostic procedures.
The first aim was major. The other two were viewed as secondary interests.
Hypotheses for Framingham Heart Study
It was assumed from the start that the CVD did not have a single cause. Rather, it was the
result of multiple causes, which worked slowly on the individual to produce the disease.
Factors that were potentially related to CVD were listed in terms of the hypotheses.
These were generated by the Framingham investigators in consultation with an advisory
committee composed of specialists representing several branches of the medical sciences.
The medical history and physical examination that would be obtained on the study
13

subjects would generate data to test these hypotheses. The major hypotheses generated
were (Dawber, 1980):
1. CVD increases with age. It occurs earlier and more frequently in males.
2. Persons with hypertension developed CVD at a greater rate than those who are not
hypertensive.
3. Elevated blood cholesterol level is associated with an increased risk of CVD.
4. Tobacco smoking is associated with an increased occurrence of CVD.
5. Habitual use of alcohol is associated with increased incidence of CVD.
6. Increased physical activity is associated with a decrease in the development of CVD.
7. An increase in thyroid function is associated with a decrease in the development of
CVD.
8. A high blood hemoglobin or hematocrit level is associated with an increased rate of
the development of CVD.
9. An increase in body weight predisposes a person to CVD.
10. There is an increased rate of the development of CVD in people with diabetes
mellitus.
11. There is higher incidence of CVD in people with gout.
These hypotheses were used directly to determine the medical history obtained and the
physical examination taken during the repeated exams of the study. Additional items
were tested as the research progressed, including fibrinogen, apoliproteins (HDL, LDL)
echocardiograms and exercise echocardiograms.
The Framingham risk score is an inexpensive tool used in the medical community
to assist in the diagnosis of individuals who are at risk for developing CHD. It allows
14

physicians to identify those who need to be examined further. The risk score is
determined by a variety of factors – systolic blood pressure, diastolic blood pressure, total
cholesterol, LDL-C, HDL-C, smoking status, diabetic status, age and gender. Each of the
factors are assigned different numerical values that are added together to identify the risk
as a percentage for the development of coronary heart disease in the next ten years.
Use of the Framingham Risk Score
Taylor, et al. (2000) investigated 79 subjects that experienced sudden death
associated with coronary heart disease. The researchers looked at the plaque development
in the subjects’ arteries through coronary segments and noticed that there were stable
plaque, plaque ruptures and erosions present. The researchers compared the evidence of
coronary heart disease (coronary segments) to the Framingham risk score to see if the
Framingham risk score accurately captured the subjects’ risk for coronary heart disease.
The study showed that there was significant disagreement between the coronary segments
and the Framingham risk score. The Framingham risk score seemed to underestimate risk
associated with atherosclerosis. In the Taylor study there were some limitations,
including a small sample size, and the mean age of subjects were 49 years, a
generalization to a larger population is difficult. The researchers investigated the
relationship between the Framingham risk score and coronary calcification and sudden
death. They measured age, gender, height, weight, total cholesterol, HDL-C, tobacco use,
and hypertension. The subject’s Framingham risk score was evaluated after death. There
was a modest but significant relationship between the calcification and Framingham risk
score. This study found that the highest Framingham risk scores in cases of sudden death
were due to plaque rupture, which is consistent with data linking hypercholesterolemia
15

and smoking with a coronary event. This study did have some limitations. Since the all
79 patients died due to a coronary thrombosis, it cannot be applied to those that survived.
The research confirmed a relationship between coronary calcification and Framingham
risk scores. The researchers also stated that this study did underestimate the Framingham
risk score in the subjects.
Richardson et al. (2008) assessed whether a community-based intervention for
men and women aged between 45-64 years without pre-existing coronary heart disease
condition prevented the development of coronary heart disease. The subjects were chosen
from an area that has a high level of social deprivation and standardized mortality rate of
CHD. This data looked at weight, body mass index (BMI), and waist circumference, as
well as behavior (i.e., smoking, alcohol, fruit and vegetable consumption and exercise).
Richardson and colleagues investigated weight, BMI, and waist circumference pre and
post intervention (exercise guidelines, smoking cessation services and a dietician) and
noticed that at the one-year follow-up weight, BMI, and waist circumference had
worsened. However pulse, systolic blood pressure, total cholesterol, HDL-C, and glucose
had improved. There were also documented behavioral changes including a decrease in
smoking, alcohol consumption and an increase in exercise, and fruit and vegetable intake.
This research showed that there could be either an overestimation or underestimation of
the Framingham risk score in identifying the development of coronary heart disease.
Vasan et al. (2005) researched adults between the ages of 35-74 with no coronary
heart disease to estimate the contributions of borderline and elevated risk factors to the
development of coronary heart disease. The researchers used both the Framingham risk
score and the Third National Health and Nutrition Examination Survey (NHANES-III).
16

The five risk factors examined were blood pressure, LDL-C, HDL-C, glucose
intolerance, smoking status. Blood glucose is used to identify whether and individual is at
risk for developing diabetes, two ways of testing is through obtaining blood when they
have eaten recently and thorough fasting, no food or fluids except for water in the last 812 hours. These were categorized at optimal, borderline and elevated levels. Additional
grouping was done with each of the risk factors into three groups—optimal risk factors,
borderline or elevated.


Characteristics that identify a subject in the borderline group include: blood pressure
value between <120/80mmHg, LDL-C value between <100mg/dL, HDL-C value
between >59, blood glucose value between <110mg/dL, fasting blood glucose value
between <140mg/dL, and a nonsmoker.



Characteristics that identify a subject in the borderline group include: blood pressure
value between 120/80-139/89mmHg, LDL-C value between 100-159mg/dL, HDL-C
value between 40-59mg/dL, impaired glucose intolerance if blood glucose value was
between 110-125mg/dL, fasting blood glucose value was between 140-199mg/dL,
and a former smoker (unidentified when subject quit).



Characteristics that identify a subject in the elevated levels group include: blood
pressure value between >140/90mmHg, LDL-C value between >159mg/dL, HDL-C
value between <40mg/dL, blood glucose value between >125mg/dL, fasting blood
glucose value between >199mg/dL and a current smoker.
The results showed that two-thirds of men and a one-third of women between the

ages of 35-44 years of age had elevated modifiable risk factors, with a low prevalence of
optimal risk factors in the United States. This research showed that currently in the
17

United States those who fall in the elevated risk factors group can be modify their lipid
values, blood pressure and blood glucose values through diet and exercise.
Domains of cardiac rehabilitation programs
Smoking and cardiovascular disease
Since the 1960s and 1970s, there have been important studies that have
contributed to the understanding of what smoking can do to the body and it’s relation to
variety of diseases including cardiovascular disease. There is an increased risk for
smokers versus nonsmokers for the development of coronary heart disease. The Multiple
Risk Factor Intervention Trial (MRFIT) researched the effects of smoking and the
development of CHD (Kuller et al., 1991, Shaten et al., 1991, Ockene et al., 1990).
Results showed a clear dose response to cigarette smoke and CHD and mortality, an
increased risk among diabetics who smoke versus nonsmoking diabetics, an additive
effect of smoking, high cholesterol levels in total cholesterol and LDL-C and elevated
blood pressure on CHD mortality (Kuller et al., 1991, Shaten et al., 1991, Ockene et al.,
1990). Shaten et al. (1991) evaluated the effect of HDL-C, LDL-C, blood pressure and
cigarette smoke as predictors for CHD. The nonsmoking subjects included had similar
blood pressure or serum total cholesterol compared to the smoking subjects. Smoking
status was self-reported. Former smokers who quit more than 12 months before the study
and nonsmokers had similar rates of CHD deaths (Shaten et al.). Smokers had an
increased rate of death due to CHD when compared to nonsmokers. LDL-C levels were
elevated among nonsmokers and when the two groups were compared they had the same
LDL levels, however smokers had a higher rate of death due to CHD (Shaten et al.).
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Benfante et al. (1991) stated that cigarette smoke is a major risk factor for CHD in
middle-aged populations; older populations had a diminished effect of cigarette smoke.
To investigate this claim, subjects between the ages of 65 to 74 years with no diagnosed
cardiovascular disease were divided into three smoking status groups (current, former and
never). Current elderly smokers smoked an average of 20 cigarettes per day compared to
24 cigarettes per day by middle-aged smokers (age 51-59 years). The elderly smoked on
average 10 years longer (Benfante et al). The relative risk for cigarette smoke and CHD
were similar between the elderly and middle-aged groups. There was an increase in
overall risk in the elderly for the development of CHD since the risk for CHD
complications increase with age (Benfante et al.).
Powell (1998) investigated the vascular damage from smoking. The products that
were combusted and absorbed into the systemic circulation caused damage to the arterial
walls through a variety of ways. The absorbed nicotine activated the release of
catecholamines (hormones that are released during times of physical and emotional
stress) while other products from the smoking injured the endothelium and promoted
atherogenesis. Smoking also increased the release of LDL-C, which adhered to the artery
walls causing the development of atherosclerosis (Powell). Smoking appeared to affect
the body on a very direct level by impairing the body’s response to the inflammation.
Nutrition and cardiovascular disease
Nutrition is an important part of preventing CHD, improving overall health and is
an important part of cardiac rehabilitation programs. Currently, the average American
diet included large amounts of salt, fat and very little fruit and vegetables (CDC, 2008).
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Researchers have investigated a variety of diets that have shown a relationship with the
development of atherosclerosis and CVD.
Millen et al. (2005) investigated a variety of factors, which included nutritional
intake, carotid ultrasound, lipid analysis, BMI, diabetes status, physical activity, and
hypertension status to identify the cause of the development of atherosclerosis. The
research subjects were from the Framingham heart study first subject pool, the offspring
cohort and the offspring-spouse cohort. The subjects were followed and evaluated every
four years for the development of carotid artery stenosis. The daily intake that was
recommended ≤ 30 % of total energy as fat, <10 % of energy as saturated fat and <300mg
of cholesterol to lower risk for developing coronary artery disease. The results showed
that smoking and dietary noncompliance doubled the odds for having carotid stenosis
compared to those with dietary compliance. Research also showed that individuals who
had carotid stenosis had a diet that was higher in total fat, saturated fat, increased sodium
intake, with lower consumption of fiber and a lower consumption of vitamins and
minerals. The subject groups, those with stenosis and those did not develop stenosis, had
low levels of physical activity. This study looked at compliance and noncompliance for
healthy nutrition and an additional grouping of smoking and nonsmoking subjects. The
results showed that a combination of a poor diet and smoking is associated with the
largest increase in atherosclerosis.
A diet that includes a high consumption of saturated and trans fats, salt, refined
carbohydrates and low levels of fruit and vegetables are associated with an increased risk
of CHD (Woodside et al., 2008). Diets high in saturated fatty acids and trans fatty acids
have been associated with CHD (Woodside et al.). Saturated fats increased LDL-C and
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total cholesterol whereas polyunsaturated fats decreased LDL-C and total cholesterol.
Within the grouping of saturated fats, there are a few that have little effect on plasma
cholesterol levels (i.e. stearic acid since it gets converted to oleic acid) (Woodside et al.).
Simply lowering fatty acid intake many not reduce CHD incidence or lower lipid profile.
However optimizing the fatty acid composition of the diet could have major benefits
(Woodside et al.). Replacing saturated fatty acids and trans fatty acids with unsaturated
fats and an increased consumption of omega-3 fatty acids, a diet high in fruits vegetables
and whole grains improved CHD risk (Woodside et al.).
Obesity and Coronary Heart Disease
Increased adipose tissue especially around the waist causes an increase of
adipokines and hormones increases an individual’s risk for CHD. Research had shown
that increased amounts of adipose tissue (especially visceral) affect the body at a cellular
level (Choi et. al., 2004). Adipose tissue is an active organ that secretes various hormones
and metabolites that are believed to regulate energy metabolism and insulin sensitivity
(Choi, et. al.). Adiponectin, a protein that is released by adipose tissue, had shown to be
important in metabolic and vascular diseases. Adiponectin increased morbidity, Creactive proteins (CrP), IL-6 (Interleukin 6) and levels of TNF- (Tissue Necrosis Factoralpha) (Moller, 2000). Adipose tissue released TNF- and IL-6 into the circulation
system and both molecules modified insulin sensitivity by interfering with the
intracellular insulin-signaling pathway (Moller, 2000). IL-6 initiated the release of CrP
from the liver to the circulation system and within the circulation system IL-6 that caused
the release of IL-1 (Interleukin-1). CrP is produced in the liver and is a reliable marker
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for systemic inflammation (Lu et al., 2004). IGFBP-1 has been related to poor glucose
control and increased mortality (Anselmino et al., 2008).
Diabetes and CHD
Diabetes affected 20.8 million individuals in America and approximately 90-95
percent of those diagnosed have type 2 diabetes (ADA, 2008). Insulin resistance, similar
to type 2 diabetes, was found in 25% of the general population (Johnstone, 2005). Eighty
percent of individuals with type 2 diabetes are overweight. Diabetes is more prevalent
among African-Americans and Hispanics populations in the United States (CDC, 2008).
Diabetes is a disease that affects metabolism. Once food enters the body, it begins
to break down. Carbohydrates are digested to form molecules of glucose, which the body
cans store or use for energy. High levels of glucose cause the release of the hormone
insulin from the β islet cells of the pancreas. In individuals with type 2 diabetes, either
there is a deficiency of insulin released or the cells ignore insulin (ADA, 2009). Since
there is an inadequate response to the β islet cells to glucose followed by a decreased
response of the peripheral tissues to insulin, this could eventually lead to a reduction of β
cells (ADA, 2009). Type 2 diabetes has lead to an increased amount of glucose in the
bloodstream and impaired response to removing the glucose. Increased amounts of
glucose can cause systemic inflammation and damage to tissue and organs, causing
neuropathy, loss of eyesight, inability to repair damage to the endothelial tissue, and
eventually death (ADA, 2009).
Diabetes is considered a risk factor for the development of atherosclerosis and
eventual diagnosis of CVD. A hypothesis for the development of atherosclerosis in
diabetic individuals was that there are chronic low levels of inflammation (Wilund,
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2007). Research had shown that exercise modified CVD risk and type 2 diabetes by
reducing systemic inflammation (Wilund, 2007). In patients that are at risk for
developing diabetes are those that are classified as obese, there was an increase risk for
cardiovascular disease. Obesity and lack of exercise had a causal link to the development
of diabetes. In diabetic individuals, exercise improved insulin sensitivity and reduced the
amount of glucose in the blood stream since the muscle requires the energy. The
mechanisms for developing diabetes are unclear and not fully understood (Wilund, 2007).
There was a direct correlation of the risk of cardiovascular mortality and
increased levels of plasma glucose concentration and HbA1c levels (Bianchi et al., 2008).
In individuals with diabetes, there was an increase in basal heart rate and cardiac output,
as well as an abnormal heart function due to autonomic neuropathy (Johnstone, 2005).
Insulin resistant individuals release higher levels of insulin for the same glucose uptake
exhibited in healthy individuals. Insulin levels approximately 100μU/mL showed
increased heart rate in obese individuals, compared to healthy individuals insulin levels
(approximately 70 μU/mL) (Johnstone, 2005).
The San Antonio Heart Study is the most comprehensive study to date that has
looked at multiple factors that can lead to cardiovascular disease (Bianchi et al., 2008).
One component of the study examined the role diet plays in various forms of
cardiovascular disease. San Antonio Heart Study subjects who did not have diabetes at
baseline, but developed type 2 diabetes by the 8-year follow-up had higher total
cholesterol and LDL values than subjects who did not develop type 2 diabetes (Bianchi et
al.). This study showed there was an increase in atherogenic factors in diabetic
individuals. Atherogenic factors are lipid oxidation products, such as cholesterol
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oxidation products, trans-fatty acids and some saturated fatty acids (Addis, 1995).
Diabetes increases the risk of having cardiovascular disease factors, including
uncontrolled cholesterol, LDL, and saturated fats.
Another physiological factor that affects the arteries and vessels in individuals
with diabetes is vasoconstriction due to lack of insulin response. In type 2 diabetes and
hypertensive patients, there is a decrease in NO production (Johnstone, 2005). The
mechanisms of insulin-mediated vasodilation in type 2 diabetes or obesity are unknown.
Nitric oxide is released from the endothelial cells and activates cyclic GMP (cGMP),
causing smooth muscle relaxation. Nitric oxide has various properties besides a
vasodilator response, including antiatherogenic properties.
Diabetes therapy included a diabetic diet, medications, weight loss and
cardiovascular exercise. When an individual was first diagnosed with diabetes, the
physician encouraged lifestyle changes to prevent uncontrolled type 2 diabetes (ADA,
2009). These changes included talking to a diabetic consultant or a registered dietitian
that developed a proper meal plan and began an exercise program, if not currently
participating in one (ADA, 2009). Prescribing insulin or secretagogue (insulin-secreting)
medications are postponed due the effects they have on the body and the difficulty they
cause with losing weight (ADA, 2009).
Individuals with type 2 diabetes are a special concern in cardiac rehabilitation
programs since exercise increases glucose uptake (American Dietetics Association,
2008). Several factors in individuals with diabetes complicated nutrition
recommendations since blood glucose levels must be regulated. According to the ADA,
there had not been much research on individuals with type 2 diabetes that examined the
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amount needed for carbohydrate, fluids and calories to perform during an exercise
session. Nutrition guidelines that were developed are based on studies in individuals who
are non-diabetic. Carbohydrate intake before, during and after exercise is important to
ensure that blood glucose does not get low. In type 2 diabetics, weight loss through diet
and exercise is important in treatment and possible prevention in borderline diabetics.
Exercise benefited patients with diabetes management by helping with glycemic
control and weight reduction. It has also been shown to reduce HbA1c, which decreased
the risk of diabetic complications (Boule et al., 2001). Exercise also improved muscle and
liver insulin sensitivity and muscle glucose uptake and utilization. Improvements in
insulin sensitivity are beneficial in type 2 diabetics. Consistent exercise caused
hypoglycemia in individuals taking insulin or insulin secretagogues. To prevent
hypoglycemia and other health complications associated with hypoglycemia, patient
medication may need to be adjusted entirely (Hayes et al., 2007). Even though exercise
has shown to be beneficial, it is still an underutilized therapeutic intervention in diabetes
management (AADE, 2007). In individuals with cardiovascular disease and diabetes,
exercise has been shown to reduce mortality and the progression of these diseases. The
exercise program needed to be monitored by the individual’s physician or exercise
professional to ensure that the individual is not harmed. Lifestyle changes are an
important factor in controlling and possibly reversing both diseases. Individuals
diagnosed with borderline type 2 diabetes and begin an exercise routine and make other
necessary lifestyle changes can slow the progression of the disease (Lavie, 1993).
Exercise and cardiovascular disease
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Exercise has been shown to reduce the deleterious effects of cardiovascular
disease. It is an important lifestyle change that should occur along with proper nutrition.
Cardiovascular disease can lead to an increase in inflammatory responses associated with
atherosclerosis and chronic inflammation (Wilund et al., 2007). Researchers have
investigated whether exercise can improve the effects of chronic inflammation. Acute
exercise has been shown to increase circulating levels of anti-inflammatory cytokines
(Wilund et al.). IL-6, TNF-α and CRP are strong independent risk factors of CVD
(Wilund et al.). IL-6 is secreted by a variety of cell types in response to IL-1 and TNF-α.
IL-6 is believed to be a traditional pro-inflammatory cytokine the increases CrP
production and is associated with unstable angina and increases the risk of future MI
(Wilund et al.). Exercise can increase the amounts of reactive oxygen species (ROS),
which are free radicals that are released by reactions to produce energy for exercise.
However it is unclear if this oxidative stress is associated with CVD risk (Wilund et al.).
Increased levels of IL-6 released during acute exercise have been shown to stimulate the
reaction of anti-inflammatory cytokines – IL-1ra, sTNFR and IL-10 (Wilund et al.).
Kohl (2001) examined five observational studies (eight publications) to evaluate
the dose response relationship between physical activity and the risk for CVD. Two of
the eight publications in the review showed no evidence for a dose response relationship
between CVD and physical activity. One study reported a mixed response between dose
response physical activity and CVD. The remaining studies observed a causal
relationship with credible evidence for a dose-response physical activity. Two out of the
five studies that observed a causal relationship were also the most recent studies, and the
subjects included elderly and women. A limitation of these studies is that CVD
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encompasses a variety of diseases and illnesses. The sample sizes of the research
examined varied in size from 36 subjects to over 4000 subjects. The exercise that the
subjects participated in was undisclosed. However, they were categorized by active or
inactive in their jobs, leisure activity and if active how much time was spent.
Besides investigating CVD and physical activity, the relationship between CHD
and physical activity has been researched. Kohl’s (2001) literature review encompasses
approximately 50 years’ worth of research. In thirty-one articles that were reviewed,
twenty articles provided support the argument that dose related response of physical
activity and its relationship to CHD, three studies showed mixed results and eight showed
no relationship between dose response physical activity and CHD (Kohl, 2001). Some of
the results showed a “U”-shaped relationship with higher relative risk of CHD at the
highest physical activity levels (Kohl, 2001). There was an inverse relationship between
exercise and blood pressure, clotting factors, glucose tolerance, and smoking habits (all
of these factors are associated with the an increased risk of CVD).
Physical activity reduces the likelihood of developing cardiovascular disease
(CVD), controls blood pressure and cholesterol (if a healthy diet is also maintained)
(Haskell, 2007). Guidelines for healthy individuals over the age of 65 and adults 50-64
years with chronic conditions should participate in moderate aerobic physical exercise for
30 minutes, five days a week or vigorous aerobic exercise for 20 minutes, three days a
week, according the position paper from AHA and ACSM (Thomas, et al., 2007). The
position paper of AACVPR, American College of Cardiology (ACC), and AHA indicates
that adherence to physical activity has been associated with a 20%-30% reduction in
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mortality in patients with cardiovascular disease (Thomas, et al). Exercise has been
shown to reduce the development and progression of atherosclerosis (Wilund, 2007).
Treatment and Care provided through Cardiac Rehabilitation Programs
Cardiac Rehabilitation programs are designed to assist patietnts to make necessary
lifestyle changes to prevent another cardiac event and return their regular daily activities.
In-hospital and post-hospital cardiac rehabilitation programs have been shown to be
beneficial in reducing the likelihood of having another event, these programs also
increase quality of life. Cardiac rehabilitation programs are shown to be beneficial in
reducing the reoccurrence of another coronary event or death (AACVPR, AHA, ACC).
However, the exact reasons the programs are beneficial are unknown. In the past, cardiac
rehabilitation programs focused primarily on cardiovascular exercise to reduce the
incidence of another coronary event. Cardiac rehabilitation programs have expanded on
that aspect of treatment and now include education to provide patients with a
multifaceted program. Cardiac rehabilitation programs reduce the risk of another
coronary event through education and cardiovascular exercise (Thomas, et al., 2007).
Cardiac rehabilitation programs that maintain data per AACVPR may provide
insight regarding whether or not cardiac rehabilitation programs are in fact reducing the
risk of another coronary event. AACVPR recommends the major domains of care and
education that a cardiac rehabilitation program should have in order to acquire and
maintain a certification. Those four domains are behavioral (education, tobacco cessation,
stress management, adherence to diet, and exercise), clinical (functional capacity, lipids,
METs, weight, blood pressure, and heart rate), health (quality of life and loss of work
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days), and service (patient satisfaction, access and utilization of service, and financial and
economic concerns).
Summary
Cardiac rehabilitation programs require proper data collection techniques and
acquisition that is standard in all programs to be able to compare them. Since the United
States government has required all cardiac rehabilitation programs to become a certified
program through AACVPR or another government certified organization. The thesis
research discussed will look at data acquired from a cardiac rehabilitation program and
evaluate the program by using the Framingham risk score. The Framingham risk score is
considered a standard form of measurement in diagnosing individuals that are at risk for
developing coronary heart disease.
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Chapter III
Methodology
This is a retrospective study looking at individuals who have completed a 36session cardiac rehabilitation program at New Heart Cardiac Rehabilitation Center to see
if that program reduced an individual’s Framingham risk score. The Framingham risk
score identifies risk factors that are known to contribute to the development and
reoccurrence of cardiovascular disease. The risk factors in the Framingham risk score are
blood pressure (systolic, diastolic), cholesterol (HDL-C, LDL-C, total cholesterol),
smoking status and diabetes.
Institutional Review Board
This research has Institutional Review Board approval from the University of New
Mexico (Appendix A).
Subjects
Subjects were recruited from a cardiac rehabilitation program in Albuquerque,
New Mexico. As this is a retrospective study, data were taken from subject files that were
acquired during the period of April 2005 to March 2008. The study included 152 male
and 46 female subjects. All subjects signed a waiver that explained the risks of the initial
walk test and the cardiac rehabilitation program (Appendix B). The waiver also had a
section stating that all of their records may be used for statistical analyses or scientific
purposes. All subjects completed a questionnaire that asked about their tobacco use,
medication compliance, etc., and all subjects completed a submaximal walk test
(Appendix C).

30

Instrument
The instrument used in this investigation was the Framingham risk score.

Inclusion/Exclusion Criteria
Individuals who had a cardiac event (myocardial infarction, PTCI, PTCA, CABG,
valve replacement and repair or a heart transplant), who completed a pre- and post-walk
test, (with lab values for both) and completed the 36-session cardiac rehabilitation
program at New Heart Cardiac Rehabilitation Center were included in the data analysis.

The exclusion criteria for the study consisted of those individuals that had a secondary
disease or illness that inhibited their ability to complete the 36-session cardiac
rehabilitation program. Data was not included for persons who could not perform the
walk test and/or did not want their data used for this research.

Experimental Protocol
Patient information was retrospectively taken from their files with approval from
the Medical Director at New Heart Cardiac Rehabilitation Center. Study approval was
granted from the University of New Mexico human subjects review committee
(Appendix A). All tests were performed at the New Heart Cardiac Rehabilitation Center
by trained staff. After their initial visit with the physician and the walk test, subjects were
scheduled for a one-on-one exercise orientation where they were shown the facility and
an exercise program was designed for them based on their needs and limitations. All
subjects were instructed to wear EKG monitors each time they exercised. Staff was
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present to help them with any questions that they may have. The subjects had a 2-week
consultation with the behavioral specialist, 4-week appointment with the cardiac
rehabilitation program coordinator and 8-week follow up with the physician and a
nutrition consultation. The time varied for each subject due to a variety of factors. All
were encouraged to exercise up to an hour 3 days per week. If patients were able and staff
felt comfortable patients were encouraged to exercise at home. After 36 sessions, all
subjects completed a post-program walk test and were evaluated by the physician.

Cardiac Rehabilitation Program
The program started with a new patient orientation where the cardiac
rehabilitation program was explained and a tour of the facility was given. All subjects at
that time scheduled their walk test and first doctor’s appointment. Each subject was given
a folder that had the necessary paperwork to be completed: a questionnaire, consent
forms for the walk test, their data and the exercise program and other items they needed
to bring with them at their next appointment. Following the walk test and the doctor’s
appointment an exercise orientation was scheduled. The staff reviewed the information in
the file and developed an exercise program based on the subject’s capabilities and
interests. If a patient wanted to participate in a triathlon in six months, the exercise staff
assisted them to achieve their goal if possible and in a healthy manner. The patient had
three additional appointments with a behavioral specialist, cardiac rehabilitation
coordinator, and the physician to assess how they were progressing and recommended
changes to their program that assisted with achieving their goals. All subjects meet with a
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registered dietician at least once to assess their diet and help them make better food
choices.
Retrospective Procedures and Data Analysis
Subjects’ data was retrospectively attained from the New Heart Cardiac
Rehabilitation Center from April 1, 2005 to December 31, 2008 from patients who
entered and completed the cardiac rehabilitation program during that time period. Pre and
post values for blood pressure (systolic, diastolic), total cholesterol, HDL-C, and LDL-C,
smoking status and diabetes status was collected by the principal investigator and placed
on to a spread sheet. The data that was collected did have the subjects name to protect
their identity a number was assigned to each subject and the spread sheet that had the
subjects named was password protected and stored on external hard drive that only the
principal investigator had access to. Using the variables listed above, a Framingham risk
score (Appendix D) was calculated and the LDL-C percentage was used. In identifying
the blood pressure’s numerical value needed for the Framingham, the systolic and
diastolic blood pressure has a table that groups the values to get a score however if the
systolic or diastolic have a higher value that value was used. The continuous variable age
was used to form a categorical variable treated as two factors (≤50 and >50 years old) to
be able to evaluate the age range that has a greater risk in comparison to the Framingham
risk score.
To evaluate each of the subject’s data and form a Framingham risk score for each
subject a program was developed using the program Labview (National Instruments,
Austin Texas). All the data that was collected during the subjects’ cardiac rehabilitation
was through a variety of cardiac rehabilitation employees and from questioning staff only
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the same treadmill was used for each subject. Delta fat intake and delta MET were
obtained by a cardiac rehabilitation employee and put on a spreadsheet. Delta fat intake
was the difference between baseline and post values of self recorded fat intake at the
current moment. Delta MET was the difference between baseline and post vales that were
obtained through their walk test, which was MET level they achieved.

Statistical Analysis
This study employed a mixed design repeated measures analysis. Gender and age
were the between-subject factors and the pre and post Framingham risk scores were the
within-subjects factor. Type 1 family-wise error was controlled with a p .05 for each
dependent variable. Using SPSS version 16, the data was analyzed using in multi-variant
analysis and multiple regression. The dependent variables in this research are delta
Framingham risk score, the baseline and 12-week scores of systolic blood pressure,
diastolic blood pressure, total cholesterol, LDL-C, HDL-C and Framingham risk score.
Independent variables are delta fat, delta MET, age binned, sex and raw age.
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Chapter IV
Results
The characteristics of the subject population are listed in Table 1. The total
population (N=198) includes women (n=46), and men (n=152).
Table 1
Summary Table
Characteristics (mean, (SD))
Age
Baseline Systolic Blood Pressure
Post Systolic Blood Pressure
Baseline Diastolic Blood Pressure
Post Diastolic Blood Pressure
Baseline Total Cholesterol
Post Total Cholesterol
Baseline LDL-C
Post LDL-C
Baseline HDL-C
Post HDL-C
Baseline Framingham Risk Score
Post Framingham Risk Score
Delta Framingham Risk Score
Delta MET
Delta Fat
Baseline Smoking Status, n
Post Smoking Status, n
Diabetes Status, n

Women
n=46
68.7 (8)
126.6 (17.8)
122.1 (17.6)
76.6 (12)
72.7 (7.6)
172 (48.7)
150.7 (29)
96.5 (43.6)
78.1 (26)
46.4 (11.5)
47.8 (8.8)
9.1 (4.7)
7 (4.3)
2.11 (3.27)
-1.08 (1.15)
3.14 (5.68)
0
0
6

Men
n=152
66.47 (10.3)
117.5 (14.4)
116.9 (15.8)
74.9 (9)
73.4 (7.9)
149.4 (40.3)
136.1 (30.1)
85.9 (34.9)
71.4 (24.2)
39.5 (12)
42.7 (11)
7.9 (5.1)
6.1 (3.6)
2.92 (4.41)
-2.07 (1.48)
2.64 (6.39)
11
3
19

Total
N=198
67 (9.8)
119.7 (15.7)
118.2 (16.2)
75.4 (9.8)
73.3 (7.8)
154.5 (43.4)
139.5 (30.5)
88.3 (37.2)
72.9 (24.8)
41.1 (12.3)
43.9 (10.7)
8.14 (4.9)
6.30 (3.8)
1.84 (3.61)
-1.82 (1.47)
2.45 (6.01)
11
3
25

*
*
*
*
*
*
*
*
*
*

*Identifies a statistically significant p value of < 0.05
Framingham Risk Scores
The difference between the baseline Framingham risk score (N=198) and 12-week
Framingham risk score (N=198) was statistically significant F(1,193) =36.37, p<.001;
partial eta squared =.15. The interaction between age and time was not significant
F(1,193) =.125, p =.725; partial eta squared =.001. The interaction between time and sex
was not statistically significant F(1,193) =1.310, p =.254; partial eta squared =.007.
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In the secondary analyses of sex and age differences, the main effect of sex was
not statistically significant F(1, 193) = 1.807, p = .180; partial eta squared = .009. The
main effect of age as a categorical variable was statistically significant F(1, 193) =
11.472, p = .001; partial eta squared = .056. The interaction of sex and age was
statistically significant F(1, 193) = 5.579, p = .019; partial eta squared= .028.
Figure 1. Comparison of baseline and post values for the Framingham risk score

Figure 1. This graph shows that the cardiac rehabilitation program had a statistically
significant affect on the Framingham Risk Score and that age and gender had an effect.
Systolic Blood Pressure
The difference between baseline systolic blood pressure (N=198) and 12 week
systolic blood pressure (N=198) was statistically significant F(1,193) = 3.391, p =.049;
and partial eta squared .020. The interaction between age and time was not significant
F(1,193) = .130, p = .719; partial eta squared = .001. The interaction between time and
sex was not statistically significant F(1,193) = 2.522, p = .114; partial eta squared = .013.
In the secondary analyses of sex and age differences, the main effect of sex is
statistically significant F(1, 193)= 6.731, p= .010; partial eta squared = .034. The main
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effect of age was not statistically significant F(1, 193) = 2.831, p = .004; partial eta
squared = .014. The interaction of sex and age was not statistically significant F(1, 193) =
.831, p = .363; partial eta squared = .004.
Figure 2. Comparison of baseline and post values for systolic blood pressure

Figure 2. Within the variable there was statistically significant and the interaction of sex.
However there was no statistical significance between the interaction of age and time, sex
and time, and the interaction of sex and age in relationship to the variable.
Diastolic Blood Pressure
The difference between baseline diastolic blood pressure (N=198) and 12 week
diastolic blood pressure (N=198) was statistically significant F (1,193) = 10.20, p = .002;
partial eta squared = .050. The interaction between age and time was not significant F
(1,193) = .270, p = .604; partial eta squared = .001. The interaction between time and sex
was not statistically significant F (1,193) = 2.069, p = .152; partial eta squared = .011.
In the secondary analyses of sex and age differences, the main effect of sex is not
statistically significant F (1, 193) = .492, p = .484; partial eta squared = .003. The main
effect of age was statistically significant F (1, 193) = 5.685, p = .018; partial eta squared
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= .028. The interaction of sex and age was not statistically significant F (1, 193) = .047,
p = .828; partial eta squared = .000.
Figure 3. Comparison of baseline and post values for diastolic blood pressure

Figure 3. Within the variable there was statistical significance and the main effect of age
was statistically significant.
Total Cholesterol
The difference between baseline total cholesterol (N=198) and 12 week total
cholesterol (N=198) was statistically significant F (1,193) = 19.777, p = .000; partial eta
squared = .093. The interaction between age and time was not significant F (1,193) =
.010, p = .921; partial eta squared = .000. The interaction between time and sex was not
statistically significant F (1,193) = 1.086, p = .299; partial eta squared = .006.
In the secondary analyses of sex and age differences, the main effect of sex was
statistically significant F (1, 193) = 13.093, p = .000 and partial eta squared = .063. The
main effect of age was not statistically significant F (1, 193) = .328, p = .567; partial eta
squared =.002. The interaction of sex and age was not statistically significant F (1, 193) =
.227, p =.634; partial eta squared = .001.
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Figure 4. Comparison of baseline and post values for total cholesterol

Figure 4. This graph shows that the cardiac rehabilitation program had an effect on the
total cholesterol values. There was a main effect of sex on the variable but not on time or
age.
LDL-C
The difference between baseline LDL-C (N=198) and 12 week LDL-C (N=198)
was statistically significant F(1,193) = 23.277, p =.000; partial eta squared = .107. The
interaction between age and time was not significant F(1,193) = .300, p = .585; partial eta
squared = .002. The interaction between time and sex was not statistically significant
F(1,193) = .239, p = .626; partial eta squared = .001.
In the secondary analyses of sex and age differences, the main effect of sex was
not statistically significant F(1, 193) = 3.809, p = .052; partial eta squared = .019. The
main effect of age was not statistically significant F(1, 193) = .285, p = .594; partial eta
squared = .001. The interaction of sex and age was not statistically significant F(1, 193) =
.053, p = .819; partial eta squared= .000.
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Figure 5. Comparison of baseline and post values for LDL-C

Figure 5. The cardiac rehabilitation program had an effect on the variable LDL-C.
However there was no other interaction regarding this variable has statistically
significant.
HDL-C
The difference between baseline HDL-C (N=198) and 12 week HDL-C (N=198)
was statistically significant F(1,193) = 8.347, p =.004; partial eta squared = .041. The
interaction between age and time was not significant F(1,193) = .030, p = .862; partial eta
squared = .000. The interaction between time and sex was not statistically significant
F(1,193) = 2.027, p = .156; partial eta squared= .010.
In the secondary analyses of sex and age differences, the main effect of sex was
statistically significant F(1, 193) = 11.060, p = .001; partial eta squared = .054. The main
effect of age was not statistically significant F(1, 193) = 2.839, p = .094; partial eta
squared = .014. The interaction of sex and age was not statistically significant F(1, 193) =
3.297, p = .071; partial eta squared= .017.
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Figure 6. Comparison of baseline and post values for HDL-C

Figure 6. There was a within variable significance due to the cardiac rehabilitation
program and there was a main effect of sex on the variable.
Multiple regression was used to identify whether there was statistical significance
between the variable delta Framingham, the difference of baseline and post assessments,
delta fat, the difference of baseline and post fat intake, and delta METs, the difference
between baseline and post MET values participants reached completing an Atterbom
walk test. There was mild statistical significance between delta fat and the delta
Framingham scores F(1, 182) = 8.556, p = .004 and R =.045 (Figure 8). There was no
statistical significance found in to between delta Framingham and delta MET F(1, 192) =
.054, p = .817 and R =.017.
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Figure 7. Comparison of the predicted delta Framingham risk score and actual delta
Framingham risk score.

Figure 7. The delta FRS (Framingham risk score) was created from calculating the
baseline and post values. The predicted values of the delta FRS is calculated by using the
multiple regression equation (Y = a + b1*X1 + b2*X2 + ... + bp*Xp).
Figure 8. Delta Framingham risk score and delta fat intake

Figure 8. The delta was created from calculating the baseline and post values in both the
Framingham risk score and their self-reported fat intake.
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Figure 9. Comparison of residual and predicted delta Framingham risk score

Figure 9. Residual scores of the Framingham risk score were calculated by subtracting
the actual values from the predicted values.
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Chapter V
Discussion

Coronary Heart disease is the leading killer of both men and women in the United
States. Individuals that have developed any form of cardiovascular disease (coronary
heart disease, coronary artery disease) and may have had an intervention (PTCI, PTCA,
CABG, etc.) are eligible for cardiac rehabilitation. To a great extent research done
validating cardiac rehabilitation programs focuses on graduation rate and occurrence of
another cardiac event. The Framingham risk score seems to be a good instrument for
evaluating cardiac rehabilitation programs. The purpose of this study was to examine the
effectiveness of a cardiac rehabilitation program in modifying a patient’s Framingham
risk score after 36 sessions of cardiac rehabilitation.
The Framingham risk score was used to evaluate a 36-session cardiac
rehabilitation program. The Framingham risk score uses an individual’s age, gender,
HDL-C, LDL-C, total cholesterol, systolic and diastolic blood pressure, diabetes and
smoking status to evaluate whether an individual will have a cardiac event within the next
ten years. The retrospective data was collected from a cardiac rehabilitation program and
a Framingham risk score was calculated. SPSS version 16 was used to evaluate the
Framingham risk score through a multivariate analysis to identify whether the
Framingham risk score and each factor that comprises the Framingham risk score are
statistically significant between baseline and post tests. In the secondary research
questions the Framingham risk score and the interaction between sex and age were
statistically significant.
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The results of the variables that were tested from baseline to 12 weeks showed
that all of the variables were statistically significant, which is not surprising since the
subjects were involved in exercise, taking prescribed medications and eating a heart
healthy diet. In the secondary research questions the Framingham risk score was
statistically significant in the interaction between sex and age and the main effect of age.
The results stated above suggested that both age and sex play a role in the Framingham
risk score.
Systolic blood pressure had a statistical significant interaction with sex, men had
lower overall values in comparison to women from baseline to post test. However
diastolic blood pressure had a statistical significant interaction with age, the exact reason
why between age is unknown. Both total cholesterol and HDL-C had statistical
significant interaction with sex from the research there appears to be an effect between
sex and cholesterol values however there is no known reason. An interaction appeared
between HDL-C and sex is not surprising since there are different clinical
recommendations due to sex.
Individuals in cardiac rehabilitation have had life changing events that change
their outlook on life. Cardiac rehabilitation programs accredited by AACVPR are
designed to address a variety of areas: behavioral (education, tobacco cessation, stress
management, adherence to diet, and exercise), clinical (functional capacity, lipids, MET
levels, weight, blood pressure, and heart rate), health (quality of life and loss of work
days), and service (patient satisfaction, access and utilization of service, and financial and
economic concerns). There has been a great deal of research on the effects exercise has
on the body. Exercise has proven to reduce the effects of diabetes, by reducing blood
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sugar levels and the progression of the disease. Exercising over a longer period of time
reduces the overall content of blood present in the circulatory system and reduces HbA1c
(Hemoglobin A1c) HbA1c is a value found in the blood that gives a picture of blood
glucose values over the last month. Besides improving the blood glucose regulation,
exercise also improves cardiac function.
There have been various investigations in the last 50 years regarding the
relationship of CHD and physical activity. Kohl (2001) has completed a literature review
that evaluated this relationship. However there was a majority of research that showed a
relationship between CHD and physical activity was inversely proportional and “U”
shaped if physical activity levels are high then there is a higher risk for CHD (Wilund,
2007). The exact reasons between higher CHD and high levels of physical activity are
unknown. Higher amounts of physical activity in individuals that already have CHD or
CVD puts additional stress on the heart that may not be able to handle it. This thesis
looked at the effect a 36-session cardiac rehabilitation program reduced the subjects
Framingham risk score. The amount of the physical activity during this current body of
research was not examined however, the risk factors that cause CHD were reduced
overall.
In cardiac rehabilitation programs there are certain factors that are monitored
closely including cholesterol levels, blood glucose, blood pressure and functional
capacity. Richardson et al. (2008) investigated individuals who had no pre-existing
cardiovascular disease to see if the Framingham risk score reduced from their baseline
assessment to the one-year follow-up. Richardson (2008) gave the participants that
needed in a dietician consultation, smoking cessation, and exercise guidelines. Since
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Richardson’s (2008) research did not examine patients with known cardiovascular
disease it does not have direct bearing on this research. However the use of the
Framingham risk score to evaluate the relationship it has with exercise, smoking and diet
modifications due. The results of the study showed that there was a reduction of the
Framingham risk score and improved levels of blood pressure and lipids and lower rates
of the development of CHD among those you maintained the program. In the subjects
that quit the program and a higher incidence of CHD and a higher Framingham risk score
(Richardson, 2008).
Cardiac rehabilitation programs exist throughout the United States and Europe.
However cardiac rehabilitation programs in these two regions differ in many ways
including the time that is spent in the program. Nieuwland et al. (2000) investigated the
difference between a low frequency and high frequency both programs that were 6-weeks
long. The high frequency consisted of two sessions per day five days per week and the
low frequency consists of 1 session per day twice a week (Nieuwland et al.). The cardiac
rehabilitation program examined in this body of research had patients attend up to three
times per week for one session per day. This protocol of three sessions per week sits right
between the low and high frequency programs.
There were baseline and post program evaluations using a submaximal cycle
ergometer test with blood pressure monitored and 12-lead EKG. Nieuwland’s research
protocol included a dietician consultation, and a meeting with a social worker or
psychologist in addition to the exercise sessions. Spouses were also encouraged to
participate in the exercise program. The New Heart Cardiac Rehabilitation program
performs a baseline and post walk test using the Atterbom protocol, with the patient
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attached to a 12-lead EKG and blood pressure monitoring. Spouses and family members
were encouraged to join so that the subjects would have a support system in place
Many of the participants were men and had uncomplicated cardiac events and
their cardiac events were relieved through surgery or medication (Nieuwland et al.). The
results of this study showed that there was an improvement in both groups and at least a
10% improvement in all areas for the low frequency group. Nieuwland’s research is
similar to the cardiac rehabilitation programs used in this body of research however the
submaximal tests are mainly walk tests and the cardiac rehabilitation programs last up to
36-sessions whereas this research lasted only 6 weeks. It was stated in the research done
by Nieuwland et al. (2000) that the participants were highly motivated individuals and
Caucasian, which makes the results difficult to apply to a larger mixed population.
Nieuwland, et al. study proves that a multifaceted approach to subjects that have
had cardiac events improves the health and reduces a subject’s risk for having another
cardiac event. This research aligns and proves the primary questions that were asked. In
both bodies of research the cardiac rehabilitation intervention improved lipid values.
Lavie et al. (1993) investigated the benefits of cardiac rehabilitation programs and
exercise training in atherosclerosis prevention in the elderly. The researchers investigated
plasma lipid levels, obesity, exercise capacity and compared it to elderly patients with
diagnosed CHD. There were marked improvements in exercise capacity, obesity indices,
and lipids levels from the baseline. Exercise improved all of the researched variables in
not only the elderly but also the younger population. This research recommended that all
participants in cardiac rehabilitation programs should have psychosocial, physical and
risk factor evaluation besides exercise training.
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Research investigated above looked at the effects cardiac rehabilitation programs
have on their subjects. The research shows that there is an improvement in the subjects
due to exercise and other interventions (Lavie, 1993). Limitations of this study are that
the participants did not accurately reflect the general population, their subjects had
cardiac events that were relied with medical intervention and no secondary health issues.
The cardiac rehabilitation program that was investigated for this research used the
Framingham risk score as the variable to evaluate the program. Many of the research
subjects may have had secondary health issues that may have complicated and influenced
their progress in the cardiac rehabilitation program. All of the participants were on
various kinds of medications to ensure that their lipid, blood pressure and blood glucose
values, which may have an effect on their improvement on the variables investigated. The
range of time that was investigated was from 6 weeks to 3 months.
Recommendations
Research needs to investigate how much time and intensity benefits individuals
with cardiac problems. Populations and research to encompass a variety of individuals
with cardiac problems and secondary health concerns to more accurately represents the
population. The Framingham risk score is a tool that is widely accepted to evaluate risk
factors that lead to the development of coronary heart disease. However there was
research that showed that it underestimated an individual’s risk for developing coronary
heart disease. The Framingham risk score needs to be modified to prevent the
underestimation of the presence of disease that has been shown from prior research.
Alternatively, a new tool needs to be developed that can better predict an individual’s risk
for developing coronary heart disease. The Framingham risk score does not look and
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excess body fat as a factor, which has been shown to increase an individual’s risk for
developing coronary heart disease. Cardiac rehabilitation programs are an important part
in improving an individual’s health after a coronary event.
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Informed Consent for Cardiovascular Disease Management Program
Explanation of Cardiovascular Disease Management Program:
You are entering Phase II Cardiac Rehab or the Cardiac Risk Reduction Program (also known as the
PHD program) that will include physical exercise, education activities and other health related
services. A limited cardiopulmonary exercise test, called a walk test, is performed as soon as possible
for accuracy of your exercise prescription, at the approval of your physician. Immediately following
the Walk Test each participant consults with one of our staff physicians. The levels of exercise which
you will undertake, will be based on your physical status, medical history and the cardiovascular
responses of any exercise tests you have had. You will be given clear instructions regarding the
amount and kind of exercise you should do. Program staff, depending on your progress and
responses to the exercise activities, will adjust your exercise prescriptions throughout the program.
Monitoring & Risk:
Your blood pressure and EKG will be monitored as required. There exists the possibility of certain
changes occurring during the exercise sessions. These include abnormal blood pressure, fainting,
disorders of the heartbeat, and in rare instances heart attack, stroke or death. Every effort will be
made to minimize these risks by a preliminary assessment and by appropriate supervision during
exercise. Emergency equipment and trained personnel are available to deal with unusual situations
that may arise.
RESPONSIBILITY OF THE PARTICIPANT:
To promote your safety and gain benefit, you should attend regularly and must follow the exercise
guidelines prescribed for you including intensity, duration, and frequency. It is the responsibility of
the participant to read the General Insurance Coverage Guidelines and Billing Policies on the back of
this form. It is the participant’s responsibility to obtain additional information regarding insurance
coverage. It is the participant’s responsibility to pay all insurance co-payments, coinsurance and
deductibles.
Use of Medical Records:
We will treat the information that is obtained during exercise testing, and while you are in the
program, as privileged and confidential information. It is not to be released or revealed to any
person, except your Cardiologist or Primary Care Physician, without your express written consent.
The information obtained, however, may be used for statistical analysis or scientific purposes with
your right to privacy retained.

I acknowledge that I have read this form in its entirety, or it has been read to me, and that I
understand the Cardiovascular Disease Management Program, Phase II Cardiac Rehab or the Cardiac
Risk Reduction Program, in which I will be engaged. I accept the risks, rules and regulations set
forth. Knowing these, and having had the opportunity to ask questions, which have been answered
to my satisfaction, I consent to participate in this program.
_________________________________

_________________________________

_________________________________

_______

Signature of Person Consenting

Signature of Witness

_______

Name of Person Consenting (please print)

Date

Date
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58

Appendix C

59

60

61

62

63

Appendix D

64

Men’s Framingham Risk Score
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Women’s Framingham Risk Score

66

References

Addia, P.B., Carr T.P., Hassel C.A., Huang Z.Z., and Warner, G.J. Atherogenic and antiatherogenic factors in the human diet. Biochemical Society Symposium (1995) 61:259-71.
American Association of Diabetes Educators (AADE). AADE Position Statement:
Diabetes and Exercise. American Association of Diabetes Educators (2007) 34(1): 37-40
Angina. Retrieved from Mayo Clinic, 2009
http://www.mayoclinic.com/health/angina/DS00994/DSECTION=symptoms
Anselmino, M., Wallander, M., Norhammar, A., Mellbin, L., and Ryden, L. Implications
of abnormal glucose metabolism in patients with coronary artery disease. Diabetes and
Vascular Disease Research (2008) 5(4): 285-290
Benfante R., Reed, D., and Frank, J. Does cigarette smoking have an independent effect
on coronary heart disease incidence in the elderly? American Journal of Public Health
(1991) 81(7): 897-899
Bianchi, C., Miccoli, R., Penno, G., and Del Prato, S. Primary prevention of
cardiovascular disease in people with dysglycemia. Diabetes Care (2008) 31(2): S208S214.
Boule, N.G., Haddad, E., Kenny, G.P., Wells, G.A., and Sigal, R.J. Effects of exercise on
glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled
clinical trials. Journal of American Medical Association (2001) 286(10):1218-1227
Cardiovascular Disease Statistics. Retrieved from The American Heart Association,
January 6, 2009. http://www.americanheart.org/presenter.jhtml?identifier=4478
Choi, K.M., Lee, J., Lee, K.W., Seo, J.A., Oh, J.H., Kim, S.G., Kim, N.H., Choi, D.S.,
and Baik, S.H. Serum adiponectin concentrations predict the developments of type 2
diabetes and the metabolic syndrome in elderly Koreans. Clinical Endocrinology (2004)
61: 75-80
Dawber, T.R., and Moore, F.E. (1952), "Longitudinal Study of Heart Disease in
Framingham, Massachusetts: An Interim Report," in Research in Public Health, Papers
presented at the 1951 Annual Conference of the Milbank Memorial Fund, 241-247.
Dawber, T.R. (1980), The Framingham Study: The Epidemiology of Atherosclerotic
Disease, Cambridge, Mass.: Harvard University Press.
Diabetes. Retrieved from the American Diabetes Association, January 5, 2009.
http://www.diabetes.org/diabetes-heart-disease-stroke.jsp
67

Diabetes. Retrieved from the World Health Organization, January 6, 2009.
http://www.who.int/diabetes/en/
Haskell, W.L., Lee, I., Pate, R.R., Powell, K.E., Blair, S.N., Franklin, B.A., Macera,
C.A., Heath, G.W., Thompson, P.D. and Bauman, A. Physical Activity and Public
Health: Updated Recommendation for Adults from the American College of Sports
Medicine and American Heart Association. Medicine and Science in Sports and Exercise
(2007) 123-1434
Hayes, C. Case Study: Exercise-related hypoglycemia in type 2 diabetes treated with oral
glucose-lowering medications. Clinical Diabetes (2007) 25:150-151
Heart Disease. Retrieved from the Center for Disease Control, September 21, 2007.
http://www.cdc.gov/nchs/fastats/heart.htm
History of the Framingham Heart Study. Retrieved from Framingham Heart Study,
December 16, 2008. http://www.framinghamheartstudy.org/about/history.html
Johnstone, M.T., and Kinzfogl, G.P. (2005) Diabetes Mellitus and heart disease. In
Johnstone, M.T. and Veves, A. Diabetes and Cardiovascular Disease Second Edition
(pp. 579-628) Totowa, NJ: Humana Press Inc.
Kohl III, H.W. Physical activity and cardiovascular disease: evidence for a dose response.
Medicine and Science in Sports and Exercise (2001) 33:S472-483
Kuller, L.H., Ockene, J.K., Meilahn, E., Wentworth, D.N., Svendsen, K.H., and Neaton,
J.D. Cigarette smoking and mortality. Preventative Medicine (1991) 20:638-654
Lavie, C.J., Milani, R.V., and Littman, A.B. Benefits of cardiac rehabilitation and
exercise training in secondary coronary prevention in the elderly. Journal of the
American College of Cardiology (1993) 22:678-683.
Lu, H., Raptis, M., Black, E., Stan, M., Amar, S., Graves, D.T. Influence of Diabetes on
the exacerbation of an inflammatory response in cardiovascular tissue. Endocrinology
(2004) 145(11): 4934-4939
Millen, B.E., Quatromoni, P.A., Nam, B., Pencina, M.J., Polak, J.F., Kimokoti, R.W.,
Ordovas, J.M., and D’Agostino, R.B. Compliance with expert population-based dietary
guidelines and lower odds of carotid atherosclerosis in women: the Framingham
Nutrition Studies. American Journal of Clinical Nutrition (2005) 82:174-180.
Moller DE., Potential Role of TNF- in the pathogenesis of insulin resistance and type 2
diabetes. Trends in Endocrinology and Metabolism. (2000) 11(6): 212-217.

68

National Diabetes Fact Sheet, 2007. Retrieved from the Center for Disease, January 12,
2008. http://apps.nccd.cdc.gov/ddtstrs/FactSheet.aspx
Nieuwland, W., Berkhuysen, M.A., van Veldhusien, D.J., Br ü�gemann, J., Landsman,
M.L.J., van Sonderen, E., Lie, K.I., Crijns, H.J.G.M., and Rispens. P. Differential effects
of high frequency versus low frequency exercise training in rehabilitation of patients with
coronary artery disease. Journal of the American College of Cardiology (2000) 36:202207.
Ockene J.K., Kuller, L.H., Svendsen, K.H., and Meilahn, E. The relationship of smoking
cessation to coronary heat disease and lung cancer in the multiple risk factor intervention
trial. American Journal of Public Health (1990) 80(8):954-958
Powell, J.T. Vascular damage from smoking: Disease mechanisms at the arterial wall.
Vascular Medicine (1998) 3(1):21-28
Richardson, G., van Woerden, H.C., Morgan, L., Edwards, R., Harries, M., Hancock, E.,
Sroczynsk, S., and Bowley, M. Healthy Hearts- A community-based primary prevention
programme to reduce coronary heart disease. BMC Cardiovascular Disorders (2008)
8:18
Rozanski, A., and Blumenthal, J. Cardiac rehabilitation, exercise training and
psychosocial risk factors: Reply. Journal of the American College of Cardiology (2006)
47:212-213
Segal, S.S. (2009) Treating Coronary Artery Disease. In Boron, W.F., Boulpaep, E.L.
Medical Physiology Second Edition (pp.585). Philadelphia, PA: Saunders.
Shaten B.J., Kuller, L.H., and Neaton, J.D. Association between baseline risk factors,
cigarette smoking, and CHD mortality after 10.5 years. Preventative Medicine (1991)
20:655-669
Silander, K., Alanne, M., Kristiansson, K., Saarela, O., Ripatti, S., Auro, K., Karvanen,
J., Kulathinal, S., Niemelä, M., Ellonen, P., Vartiainen, E., Jousilahti, P., Saarela, J.,
Kuulasmaa, K., Evans, A., Perola, M., Salomaa, V., and Peltonen, L., Gender differences
in genetic risk profiles for cardiovascular disease. PLOS One (2008) 3(10):e3615.
Taylor A.J., Burke, A.P., O’Malley, P.G., Farb, A., Malcom, G.T., Smialek, J., and
Virmani, R. A comparison of the Framingham risk index, coronary artery clacification
and culprit plaque morphology in sudden cardiac death. Circulation (2000) 101:12431248
Thomas, R.J., King, M., Lui, K., Oldridge, N., Piña, I.L., Spertus, J., and ACC/AHA
Task Force Members. AACVPR/ACC/AHA 2007 Performance measures on cardiac
rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention
services. Journal of Cardiopulmonary Rehabilitation and Prevention (2007) 27:260-290
69

Vasan, R.S., Sullivan, L.M., Wilson, P.W.F., Sempos, C.T., Sundström, J., Kannel, W.B.,
Levy, D., and D’Agostino, R.B. Relative importance of borderline and elevated levels of
coronary heart disease risk factors. Annals of Internal Medicine (2005) 142:393-402
Wilund, K.R. Is the anti-inflammatory effect of regular exercise responsible for reduced
cardiovascular disease? Clinical Science (2007) 112:543-555
Woodside JV, McKinley MC, and Young IS. Saturated and trans fatty acids and coronary
heart disease. Current Atherosclerosis Rep. 2008 Dec;10(6):460-6. Links World Health
Organization, 2008

70

